You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Drug Price Trends for NDC 45802-0088


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 45802-0088

Drug Name NDC Price/Unit ($) Unit Date
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.56359 GM 2025-03-19
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.53475 GM 2025-02-19
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.35969 GM 2025-01-22
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.32051 GM 2024-12-18
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.02335 GM 2024-11-20
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.53560 GM 2024-10-23
ALBUTEROL HFA 90 MCG INHALER 45802-0088-01 2.62873 GM 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 45802-0088

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 45802-0088

Introduction

The drug with the National Drug Code (NDC) 45802-0088 is an albuterol sulfate inhalation solution, specifically a suspension formulation. This analysis will delve into the market dynamics, pricing mechanisms, and projections for this medication.

Market Context

Demand and Usage

Albuterol sulfate is a widely used medication for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The demand for this drug is consistent due to the prevalence of these respiratory conditions. According to the EPA's analysis, the market for metered dose inhalers (MDIs), which include albuterol sulfate products, saw significant sales in the U.S., with an estimated 144 million HFC MDIs sold in 2020[3].

Market Share and Competition

The market for albuterol sulfate inhalers is competitive, with multiple manufacturers and generic versions available. The NDC 45802-0088 is associated with Perrigo Co., one of the several companies producing this medication. The competition in this market segment is high, which can influence pricing and market share[1].

Pricing Mechanisms

Average Wholesale Price (AWP)

The Average Wholesale Price (AWP) is a critical metric in the pharmaceutical industry, although it has been subject to controversy and legal challenges. AWP is supposed to reflect the average price at which a drug is sold at the wholesale level. However, it has been alleged that some drug companies manipulate AWP to inflate reimbursement costs, particularly for Medicare and Medicaid[2].

For the NDC 45802-0088, the AWP would be a benchmark for pricing, but it is essential to note that actual prices can vary based on several factors, including the specific market, distribution channels, and negotiations between manufacturers and payers.

Actual Acquisition Costs

The Actual Acquisition Cost (AAC) or the National Average Drug Acquisition Cost (NADAC) is often considered a more accurate reflection of the prices pharmacies pay for medications. These costs are reported annually by Medicaid and can provide a clearer picture of the market pricing for albuterol sulfate inhalers[3].

Price Projections

Historical Pricing Trends

Historical data shows that prices for generic medications like albuterol sulfate can fluctuate but generally tend to stabilize or decrease over time due to competition. For instance, the prices of generic inhalers have seen a mix of increases and decreases, influenced by factors such as changes in manufacturing costs, regulatory pressures, and market competition[1].

Future Pricing Projections

Given the competitive nature of the market and the presence of multiple generic versions, it is likely that the prices for NDC 45802-0088 will remain stable or see a slight decrease in the coming years. Here are some key factors influencing these projections:

  • Competition: The presence of multiple generic manufacturers will continue to drive competition, potentially leading to lower prices.
  • Regulatory Environment: Any changes in regulatory policies or enforcement actions against price manipulation could impact pricing.
  • Market Demand: Stable demand due to the chronic nature of the conditions treated by albuterol sulfate will maintain a consistent market size.

Statistical Insights

  • The sales analysis for MDIs, including albuterol sulfate products, indicates a growth rate of approximately 1% per year through 2025, aligned with population growth[3].
  • The average charge size and propellant quantity per unit can also influence the overall cost, but these are expected to remain relatively stable.

Key Takeaways

  • The market for albuterol sulfate inhalers, including NDC 45802-0088, is competitive and influenced by multiple factors such as AWP, AAC, and regulatory environments.
  • Historical pricing trends suggest stability or slight decreases in prices due to competition.
  • Future projections indicate stable or slightly decreasing prices, driven by competition and stable demand.

FAQs

What is the NDC 45802-0088?

The NDC 45802-0088 is an albuterol sulfate inhalation solution, specifically a suspension formulation, used for treating asthma and COPD.

What is the Average Wholesale Price (AWP)?

AWP is the average price at which a drug is sold at the wholesale level, though it has been subject to controversy and allegations of manipulation.

How does competition affect the price of NDC 45802-0088?

Competition from multiple generic manufacturers tends to drive prices down, making the medication more affordable for consumers.

What are the key factors influencing price projections for NDC 45802-0088?

Key factors include competition, regulatory environment, and stable market demand due to the chronic nature of the treated conditions.

How does the regulatory environment impact pricing?

Changes in regulatory policies or enforcement actions against price manipulation can significantly impact the pricing of medications like albuterol sulfate.

What are the expected growth rates for MDI sales, including albuterol sulfate products?

The growth rate for MDI sales, including albuterol sulfate products, is projected to be approximately 1% per year through 2025, aligned with population growth.

Sources

  1. Nevada Essential Drug List 2021 - Nevada Department of Health and Human Services[1]
  2. AWP Fact or Fiction - MSP Network[2]
  3. Market Characterization of the U.S. Metered Dose Inhaler Industry - EPA[3]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.